NASDAQ:RETA
Reata Pharmaceuticals, Inc.
- Stock
Last Close
172.32
25/09 20:00
Market Cap
6.57B
Beta: 1.53
Volume Today
1.91M
Avg: 1.45M
PE Ratio
−81.11
PFCF: −26.32
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -35.10M - | 689K 101.96% | -1.45M 310.45% | -6.23M 329.45% | -47.67M 665.55% | -80.55M 68.96% | -290.17M 260.25% | -247.75M 14.62% | -297.39M 20.03% | -311.90M 4.88% | |
depreciation and amortization | 2.93M - | 2.51M 14.18% | 1.82M 27.59% | 682K 62.51% | 437K 35.92% | 431K 1.37% | 932K 116.24% | 1.14M 21.89% | 1.20M 5.90% | 1.13M 6.07% | |
deferred income tax | 1.01M - | 11.18M - | |||||||||
stock based compensation | 2.36M - | 1.52M 35.49% | 2.08M 36.24% | 2.37M 14.07% | 6.53M 175.88% | 10.55M 61.56% | 26.38M 150.06% | 57.63M 118.46% | 56.81M 1.43% | 58.73M 3.39% | |
change in working capital | -1.38M - | -111.87M 8,030.31% | -64.87M 42.02% | -16.08M 75.21% | -42.69M 165.47% | -16.11M 62.26% | 10.33M 164.12% | -172.68M 1,771.34% | -49.58M 71.29% | 9.31M 118.78% | |
accounts receivables | -223K - | 198K 188.79% | |||||||||
inventory | 2.36M - | -603K 125.58% | |||||||||
accounts payables | 182K - | -1.66M 1,009.89% | 2.75M 266.30% | 299K 89.14% | -1.76M 689.63% | 1.96M 210.89% | -2.11M 208.13% | 2.88M 236.19% | 8.71M 202.64% | 5.20M 40.31% | |
other working capital | -1.56M - | -109.99M 6,959.95% | -67.82M 38.34% | -16.38M 75.85% | -40.93M 149.86% | -18.07M 55.85% | 12.45M 168.88% | -175.56M 1,510.59% | -58.29M 66.80% | 4.11M 107.05% | |
other non cash items | -37.75M - | 18.52M 149.05% | 17.80M 3.86% | 138K - | 888K 543.48% | 1.37M 54.73% | 28.14M 1,948.25% | 53.25M 89.22% | 38.46M 27.77% | ||
net cash provided by operating activities | -68.95M - | -88.63M 28.55% | -44.62M 49.66% | -19.26M 56.84% | -83.26M 332.30% | -83.78M 0.63% | -251.15M 199.76% | -322.34M 28.35% | -235.70M 26.88% | -204.27M 13.34% | |
investments in property plant and equipment | -325K - | -183K 43.69% | -272K 48.63% | -340K 25% | -344K 1.18% | -679K 97.38% | -2.67M 293.67% | -927K 65.32% | -1.33M 43.37% | -3.27M 146.05% | |
acquisitions net | |||||||||||
purchases of investments | -661.89M - | ||||||||||
sales maturities of investments | 320M - | ||||||||||
other investing activites | 2.48M - | 43K 98.26% | 12K 72.09% | 1K 91.67% | 1K 0% | ||||||
net cash used for investing activites | 2.15M - | -140K 106.51% | -260K 85.71% | -339K 30.38% | -343K 1.18% | -679K 97.96% | -2.67M 293.67% | -927K 65.32% | -1.33M 43.37% | -345.16M 25,871.71% | |
debt repayment | -45K - | -45K 0% | -45K 0% | -167.17M - | |||||||
common stock issued | 64.70M - | 108.91M 68.32% | 233.50M 114.39% | 492.45M 110.90% | 333.28M 32.32% | 333.28M 0% | |||||
common stock repurchased | -145K - | ||||||||||
dividends paid | -460K - | ||||||||||
other financing activites | 2.26M - | -825K - | -2.34M 183.39% | 19.78M 946.11% | 58.98M 198.13% | 87.91M 49.05% | 310.99M 253.77% | -324.14M 204.23% | 1.49M 100.46% | ||
net cash used provided by financing activities | 1.65M - | 1K 99.94% | -870K 87,100% | 62.32M 7,263.45% | 128.65M 106.42% | 292.47M 127.34% | 580.36M 98.43% | 477.09M 17.79% | 9.14M 98.08% | 1.49M 83.75% | |
effect of forex changes on cash | |||||||||||
net change in cash | -65.14M - | -88.77M 36.27% | -45.75M 48.46% | 42.72M 193.39% | 45.05M 5.44% | 208.01M 361.75% | 326.53M 56.98% | 153.83M 52.89% | -227.89M 248.15% | -547.95M 140.44% | |
cash at beginning of period | 241.67M - | 176.53M 26.96% | 87.76M 50.29% | 42.01M 52.13% | 84.73M 101.70% | 129.78M 53.17% | 337.79M 160.28% | 664.32M 96.67% | 818.15M 23.16% | 590.26M 27.85% | |
cash at end of period | 176.53M - | 87.76M 50.29% | 42.01M 52.13% | 84.73M 101.70% | 129.78M 53.17% | 337.79M 160.28% | 664.32M 96.67% | 818.15M 23.16% | 590.26M 27.85% | 42.31M 92.83% | |
operating cash flow | -68.95M - | -88.63M 28.55% | -44.62M 49.66% | -19.26M 56.84% | -83.26M 332.30% | -83.78M 0.63% | -251.15M 199.76% | -322.34M 28.35% | -235.70M 26.88% | -204.27M 13.34% | |
capital expenditure | -325K - | -183K 43.69% | -272K 48.63% | -340K 25% | -344K 1.18% | -679K 97.38% | -2.67M 293.67% | -927K 65.32% | -1.33M 43.37% | -3.27M 146.05% | |
free cash flow | -69.27M - | -88.81M 28.21% | -44.89M 49.45% | -19.60M 56.34% | -83.60M 326.55% | -84.46M 1.03% | -253.82M 200.52% | -323.27M 27.36% | -237.03M 26.68% | -207.54M 12.44% |
All numbers in USD (except ratios and percentages)